Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Breaking the Cost Barrier: How Quantization Enables Efficient Development and Deployment of LLMs for Public Healthcare

View ORCID ProfileAndrew Maranhão Ventura D’addario
doi: https://doi.org/10.1101/2025.11.17.25340460
Andrew Maranhão Ventura D’addario
1Independent researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Maranhão Ventura D’addario
  • For correspondence: andrew_dadario{at}hotmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The clinical promise of Large Language Models (LLMs) is often unrealized due to pro-hibitive computational costs. These costs create barriers not only to deployment in patient care but also to the vital process of fine-tuning models for specialized medical tasks and local patient populations. This study investigates 4-bit quantization as a methodology to make the entire clinical AI lifecycle—from development to implementation—both financially and practically viable. We performed a cost-benefit analysis using the Gemma 3 model family on the HealthQA-BR medical benchmark. We compared the diagnostic accuracy and computational resource requirements of standard full-precision models against their 4-bit quantized counterparts during both inference (clinical use) and QLoRA-based fine-tuning (model development). Quantization enabled massive efficiency gains with a clinically negligible impact on performance. For the 12B-parameter model, we observed a mere 1.3% absolute drop in accuracy. In exchange, computational requirements were reduced by 80% for fine-tuning and 69% for inference. This translates to a more than three-fold improvement in performance per unit of computational cost, accelerating research and development cycles. 4-bit quantization is a pivotal enabling technology for clinical AI. By drastically lowering the resource barrier for model customization and deployment, it empowers medical institutions to rapidly develop and validate specialized AI tools on-site. This approach holds particular promise for large-scale public health systems like Brazil’s SUS and provides a viable blueprint for similar health systems worldwide to transform AI from a theoretical possibility into a practical and equitable reality in patient care.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Brazilian Ministry of Health (MoH/DECIT) in partnership with the National Council for Scientific and Technological Development (CNPq) [grant number 400757/2024-9] and the Gates Foundation. The Author Accepted Manuscript version arising from this submission will be published under a Creative Commons Attribution 4.0 Generic License.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced are available online at: https://huggingface.co/datasets/Larxel/healthqa-br

https://huggingface.co/datasets/Larxel/healthqa-br

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 19, 2025.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Breaking the Cost Barrier: How Quantization Enables Efficient Development and Deployment of LLMs for Public Healthcare
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Breaking the Cost Barrier: How Quantization Enables Efficient Development and Deployment of LLMs for Public Healthcare
Andrew Maranhão Ventura D’addario
medRxiv 2025.11.17.25340460; doi: https://doi.org/10.1101/2025.11.17.25340460
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Breaking the Cost Barrier: How Quantization Enables Efficient Development and Deployment of LLMs for Public Healthcare
Andrew Maranhão Ventura D’addario
medRxiv 2025.11.17.25340460; doi: https://doi.org/10.1101/2025.11.17.25340460

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (576)
  • Allergy and Immunology (868)
  • Anesthesia (306)
  • Cardiovascular Medicine (4483)
  • Dentistry and Oral Medicine (449)
  • Dermatology (385)
  • Emergency Medicine (615)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1528)
  • Epidemiology (15283)
  • Forensic Medicine (31)
  • Gastroenterology (1134)
  • Genetic and Genomic Medicine (6651)
  • Geriatric Medicine (671)
  • Health Economics (1006)
  • Health Informatics (4606)
  • Health Policy (1378)
  • Health Systems and Quality Improvement (1624)
  • Hematology (545)
  • HIV/AIDS (1276)
  • Infectious Diseases (except HIV/AIDS) (15965)
  • Intensive Care and Critical Care Medicine (1111)
  • Medical Education (626)
  • Medical Ethics (147)
  • Nephrology (675)
  • Neurology (6699)
  • Nursing (346)
  • Nutrition (1006)
  • Obstetrics and Gynecology (1153)
  • Occupational and Environmental Health (961)
  • Oncology (3370)
  • Ophthalmology (989)
  • Orthopedics (370)
  • Otolaryngology (421)
  • Pain Medicine (437)
  • Palliative Medicine (131)
  • Pathology (670)
  • Pediatrics (1704)
  • Pharmacology and Therapeutics (700)
  • Primary Care Research (717)
  • Psychiatry and Clinical Psychology (5497)
  • Public and Global Health (9288)
  • Radiology and Imaging (2225)
  • Rehabilitation Medicine and Physical Therapy (1375)
  • Respiratory Medicine (1202)
  • Rheumatology (598)
  • Sexual and Reproductive Health (721)
  • Sports Medicine (536)
  • Surgery (722)
  • Toxicology (100)
  • Transplantation (290)
  • Urology (267)